NO20091571L - Markorgener for anvendelse ved identifisering av kondrocyttfenotypiskstabilitet og ved screeningav faktorer som innvirker pabruskdannelse - Google Patents
Markorgener for anvendelse ved identifisering av kondrocyttfenotypiskstabilitet og ved screeningav faktorer som innvirker pabruskdannelseInfo
- Publication number
- NO20091571L NO20091571L NO20091571A NO20091571A NO20091571L NO 20091571 L NO20091571 L NO 20091571L NO 20091571 A NO20091571 A NO 20091571A NO 20091571 A NO20091571 A NO 20091571A NO 20091571 L NO20091571 L NO 20091571L
- Authority
- NO
- Norway
- Prior art keywords
- screening
- pabrus
- identifying
- formation
- marker genes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Det beskrives et sett av gener som kan benyttes for å predikere potensialet for en cellepopulasjon til å danne brusk etter implantering in vivo. Settet av markører benyttes blant annet som en kvalitetskontroll for celler og i screeninganalyser for å evaluere innvirkningen av forbindelser og betingelser på cellenes bruskdannende evne.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86715206P | 2006-11-24 | 2006-11-24 | |
PCT/EP2007/010285 WO2008061804A2 (en) | 2006-11-24 | 2007-11-23 | Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20091571L true NO20091571L (no) | 2009-08-14 |
NO342020B1 NO342020B1 (no) | 2018-03-12 |
Family
ID=39323853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091571A NO342020B1 (no) | 2006-11-24 | 2009-04-21 | Markørgener for anvendelse ved identifisering av kondrocyttfenotypisk stabilitet og ved screening av faktorer som innvirker på bruskdannelse |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100068715A1 (no) |
EP (1) | EP2094310B1 (no) |
JP (1) | JP5455219B2 (no) |
CN (1) | CN101616693A (no) |
AU (1) | AU2007324705B2 (no) |
CA (1) | CA2670419C (no) |
ES (1) | ES2452825T3 (no) |
HK (1) | HK1136964A1 (no) |
IL (1) | IL198799A (no) |
NO (1) | NO342020B1 (no) |
NZ (1) | NZ576360A (no) |
RU (1) | RU2508548C2 (no) |
WO (1) | WO2008061804A2 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0902793D0 (en) | 2009-02-20 | 2009-04-08 | Univ Gent | GDF15 as molecular tool to monitor and enhance phenotypic stability of articular chondrocytes |
US9593385B2 (en) * | 2011-01-26 | 2017-03-14 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Selective detection of Haemophilus influenzae |
US20140255364A1 (en) * | 2011-10-28 | 2014-09-11 | Tufts University | 3d culture system for culturing cells in synovial fluid, cells cultured in synovial fluid and their use |
DE102014201528A1 (de) * | 2013-03-27 | 2014-10-02 | Tetec Tissue Engineering Technologies Ag | In vitro-Verfahren zur prognostischen Beurteilung der Erfolgsaussichten einer Implantation und/oder Transplantation |
JP2014230493A (ja) * | 2013-05-28 | 2014-12-11 | 三菱レイヨン株式会社 | 間葉系幹細胞からの分化状態を識別する遺伝子群及び分化状態の評価方法 |
CN106581666A (zh) * | 2016-11-23 | 2017-04-26 | 新乡医学院 | Pedf在制备治疗糖尿病骨组织并发症药物中的应用 |
EP3417888A1 (de) * | 2017-06-25 | 2018-12-26 | co.don AG | Verfahren zum herstellen von transplantierbarem knorpelgewebe |
RU2765437C1 (ru) * | 2021-08-17 | 2022-01-31 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ГБ им. Гельмгольца" Минздрава России) | Способ определения уровня экспрессии гена, кодирующего PEDF, в тканях глаза кролика Oryctolagus cuniculus и набор для его определения |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4981797A (en) * | 1996-10-11 | 1998-05-11 | Government Of The United States Of America, The | Isolation and method of using tissue growth-inducing frzb protein |
DE10048710A1 (de) | 1999-09-27 | 2001-10-04 | Gabriele Pecher | Pharmazeutische Zusammensetzung zur Behandlung und Prophylaxe von humanen Tumoren, die das Tumorantigen Muzin und/oder das Carcinoembryonale Antigen (CEA) exprimieren und ihre Verwendung |
US7482114B2 (en) * | 1999-10-06 | 2009-01-27 | Tigenix N.V. | In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation |
WO2001024833A2 (en) | 1999-10-06 | 2001-04-12 | Tigenix N.V. | In vivo assay for testing the phenotypic stability |
DE20023640U1 (de) | 1999-10-06 | 2005-06-23 | Tigenix N.V. | Isolierung von Vorläuferzellen und deren Verwendung zum Wiederaufbau von Bindegewebe |
US20020009730A1 (en) * | 1999-11-17 | 2002-01-24 | Alex Chenchik | Human stress array |
RU2209433C2 (ru) * | 2000-06-19 | 2003-07-27 | Российский научный центр "Восстановительная травматология и ортопедия" им. акад. Г.А.Илизарова | Способ определения показаний к внутрисуставному введению хондропротекторов на основе гидролизата гликозаминогликанов хряща |
US20020061514A1 (en) | 2000-09-21 | 2002-05-23 | Underhill Tully Michael | Assay for identifying modulators of chondrogenesis |
US20040265808A1 (en) | 2001-04-05 | 2004-12-30 | Teresa Garcia | Genes involved in osteogenesis, and methods of use |
GB0301977D0 (en) | 2003-01-28 | 2003-02-26 | Daniolabs Ltd | Method for creating a model amenable to high-throughput screening |
-
2007
- 2007-11-23 NZ NZ576360A patent/NZ576360A/en not_active IP Right Cessation
- 2007-11-23 AU AU2007324705A patent/AU2007324705B2/en not_active Revoked
- 2007-11-23 CN CN200780043440A patent/CN101616693A/zh active Pending
- 2007-11-23 JP JP2009537561A patent/JP5455219B2/ja not_active Expired - Fee Related
- 2007-11-23 US US12/515,488 patent/US20100068715A1/en not_active Abandoned
- 2007-11-23 ES ES07846847.7T patent/ES2452825T3/es active Active
- 2007-11-23 RU RU2009123960/15A patent/RU2508548C2/ru not_active IP Right Cessation
- 2007-11-23 CA CA2670419A patent/CA2670419C/en not_active Expired - Fee Related
- 2007-11-23 WO PCT/EP2007/010285 patent/WO2008061804A2/en active Application Filing
- 2007-11-23 EP EP07846847.7A patent/EP2094310B1/en active Active
-
2009
- 2009-04-21 NO NO20091571A patent/NO342020B1/no not_active IP Right Cessation
- 2009-05-18 IL IL198799A patent/IL198799A/en active IP Right Grant
-
2010
- 2010-03-01 HK HK10102131.4A patent/HK1136964A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2008061804A3 (en) | 2008-07-17 |
JP5455219B2 (ja) | 2014-03-26 |
CA2670419C (en) | 2018-07-17 |
IL198799A0 (en) | 2011-08-01 |
JP2010509927A (ja) | 2010-04-02 |
CN101616693A (zh) | 2009-12-30 |
IL198799A (en) | 2013-08-29 |
NZ576360A (en) | 2011-07-29 |
US20100068715A1 (en) | 2010-03-18 |
AU2007324705B2 (en) | 2013-09-05 |
HK1136964A1 (en) | 2010-07-16 |
CA2670419A1 (en) | 2008-05-29 |
WO2008061804A2 (en) | 2008-05-29 |
RU2009123960A (ru) | 2010-12-27 |
NO342020B1 (no) | 2018-03-12 |
ES2452825T3 (es) | 2014-04-02 |
EP2094310B1 (en) | 2013-12-25 |
RU2508548C2 (ru) | 2014-02-27 |
EP2094310A2 (en) | 2009-09-02 |
AU2007324705A1 (en) | 2008-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20091571L (no) | Markorgener for anvendelse ved identifisering av kondrocyttfenotypiskstabilitet og ved screeningav faktorer som innvirker pabruskdannelse | |
Shi et al. | Genome-centric metatranscriptomics analysis reveals the role of hydrochar in anaerobic digestion of waste activated sludge | |
He et al. | Performance and microbial community responses of anaerobic digestion of waste activated sludge to residual benzalkonium chlorides | |
Álvarez et al. | A methodology for optimising feed composition for anaerobic co-digestion of agro-industrial wastes | |
Meulepas et al. | Effect of methanogenic substrates on anaerobic oxidation of methane and sulfate reduction by an anaerobic methanotrophic enrichment | |
DK1720979T3 (da) | Anvendelse af et serumfrit celledyrkningsmedium til fremstilling af IL-18BP I pattedyrceller | |
Mahmoud et al. | Changes in glucose fermentation pathways as a response to the free ammonia concentration in microbial electrolysis cells | |
GB2446525A (en) | Stem cell culture medium and method | |
DK2218776T3 (da) | Dyreproteinfrit celledyrkningsmedie til dyrkning af celler | |
TW200734462A (en) | Regulating stem cells | |
WO2007117262A3 (en) | Culture of non-embryonic cells at high cell density | |
O'Reilly et al. | Effect of influent COD/SO42− ratios on mesophilic anaerobic reactor biomass populations: physico-chemical and microbiological properties | |
GB2451523A8 (en) | Pluripotent cells from rat and other species | |
WO2007016485A3 (en) | Use of a gsk-3 inhibitor to maintain potency of cultured cells | |
RU2011121842A (ru) | Дифференцирование человеческих эмбриональных стволовых клеток в линию панкреатических эндокринных клеток | |
EA200800996A1 (ru) | Способ получения т-клеточной популяции | |
DK2213287T3 (da) | Inhibering af biofilmdannelse | |
WO2009132083A3 (en) | Compositions and methods for promoting the generation of pdx1+ pancreatic cells | |
DK1807504T3 (da) | Serumfrit cellekulturmedium til celler fra pattedyr | |
Tekari et al. | Chondrocytes expressing intracellular collagen type II enter the cell cycle and co‐express collagen type I in monolayer culture | |
ATE493687T1 (de) | Methode zur herstellung einer versiegelten zellstruktur | |
EP2172231A4 (en) | TREATMENTS MANUFACTURED BY TISSUE ENGINEERING AND VITRO CONSTRUCTION PROCESSES THEREFOR | |
Wang et al. | Coconut shell ash enhances short-chain fatty acids production from anaerobic algae fermentation | |
Chen et al. | Variable sediment methane production in response to different source-associated sewer sediment types and hydrological patterns: Role of the sediment microbiome | |
Iasakov et al. | The Baltic Sea methane pockmark microbiome: The new insights into the patterns of relative abundance and ANME niche separation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |